Detection of Sepsis Occurrence by Using Blood Fluorescence
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNingbo Medical Center Lihuili Hospital
About this trial
This study adopted a case-control study method to explore a reagent-free, highly sensitive, and frequently screened blood fluorescence metabolite analyzer for sepsis, which can detect the emergence of inflammatory free radicals before organ damage and shorten the diagnosis time of sepsis.
Eligibility criteria
Qualifiers
Healthy control group: Individuals who are physically healthy with no underlying diseases and have not been hospitalized within the past two years. Recruitment for healthy volunteers will be conducted through notices and online media.
Sepsis Experimental Group: Patients with confirmed infections, having qSOFA ≥ 2 and SOFA ≥ 2, will be screened and confirmed by a physician to meet the inclusion criteria.
Non-septic Severe Control Group: Patients with suspected or confirmed infections, having a SOFA score of 1, will be screened and confirmed by a physician to meet the inclusion criteria.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Blood fluorescence metabolite analysis
Treatment groups
800 Participants
are divided into 4 treatment groupsSponsors and collaborators
Ningbo Medical Center Lihuili Hospital
Lead sponsor
University of Macau
Collaborator
Source ClinicalTrials.gov